logo
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia
Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: Randomized controlled trial
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data
Ambulatory quality indicators to prevent infection in sickle cell disease
Partial dysfunction of Treg activation in sickle cell disease
Sickle-cell disease stroke throughout life: A retrospective study in an adult referral center
Angiogenic growth factors augment K–Cl cotransporter expression in erythroid cells via hypoxia-inducible factor-1α
Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia
Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene
Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients
Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database
X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations
Specific macrothrombocytopenia/hemolytic anemia associated with sitosterolemia
World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management
Auer-rod like inclusions in multiple myeloma
Laboratory tests for paroxysmal nocturnal hemoglobinuria
The different faces of myelodysplasia in peripheral blood granulocytes
A refined approach to detect and measure minimal residual disease in childhood acute myeloid leukemia by flow cytometry
Restoration of response to ruxolitinib upon brief withdrawal in two patients with myelofibrosis
Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders